Market Overview:

The Immunoprecipitation Market size is estimated to reach $1.7 Billion by 2031, growing at a CAGR of 5.5% during the forecast period 2025-2031, according to a recent report published by IndustryARC, titled, “Immunoprecipitation Market – By Product Type (Kits & Reagents, Instruments), By Technology (Magnetic Bead-Based Immunoprecipitation, Column-Based Immunoprecipitation, Spin Column-Based Immunoprecipitation, Immunoprecipitation with Fluorescence Detection, Others), By Sample Type (Cell Lysates, Tissue Samples, Blood & Serum, Others), By Application (Protein-Protein Interaction, Post-Translational Modifications (PTMs), Antibody Purification, Enzyme-Substrate Interaction, Chromatin Immunoprecipitation (ChIP), RNA Immunoprecipitation (RIP), Others), By End Use Industry (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Hospitals & Diagnostic Laboratories, Others), By Geography - Global Opportunity Analysis & Industry Forecast, 2025-2031”
The need for precise protein analysis is growing with the proteomics research. Immunoprecipitation techniques are being improved by advancements in antibody development. New applications for immunoprecipitation are arising from the expansion of epigenetics and transcriptomics research. Advanced immunoprecipitation methods are being adopted due to increasing R&D investments. The efficiency and accuracy of immunoprecipitation processes are being improved by technological innovations.

North America Dominated the Market in 2023:

Strong governmental support for life sciences and research innovation makes North America the largest immunoprecipitation market. Innovation, Science, and Economic Development Canada (ISED) 2024-25 Departmental Plan includes large investments in biomanufacturing and life sciences, including $225 million for AbCellera, a biotechnology leader. This is a broader regional focus on building research excellence and innovation. New immunoprecipitation technologies often require cutting edge technologies, and ISED’s support of AI and quantum technologies supports these new technologies. The market is in a state of rapid evolution and North America is well cemented as the leading force with the robust funding environment and initiatives aimed at bolstering SMEs and forging research partnerships.

Immunoprecipitation Market: Key Takeaways

Advancements in Antibody Development:

The immunoprecipitation market is being driven by the advancements in antibody development, especially with the advancement in monoclonal antibody technology. For example, in September 2024, ImmunoPrecise Antibodies Ltd. (IPA) recently achieved important developments in rabbit monoclonal antibody development using its proprietary B Cell Select® platform.  By this development, antibodies such as OR502 and OR641 were advanced to the clinic for the treatment of cancer. Dual targeting antibodies are increasingly recognized as having therapeutic potential, and these breakthroughs include dual targeting antibodies. High throughputs in IPA’s discovery methods have greatly increased the efficiency of antibody creation, speeding up development and bringing them into clinical trials.
 
For More Queries About "Immunoprecipitation Market " @ https://www.industryarc.com/pdfdownload.php?id=800838

Expansion of Epigenetics and Transcriptomics Research:

Increasing focus on epigenetics and transcriptomics research is one of the major drivers in the immunoprecipitation. A $4 million funding boost in December 2024 by the National Health and Medical Research Council (NHMRC) to researchers at The University of Western Australia (UWA) underpins this trend. Among them, Associate Professor Pilar Blancafort, with work on cancer epigenetics, and Professor Ryan Lister, with work on pluripotent stem cells, stand out for their growing applications in medical research. To meet these needs, such technologies as immunoprecipitation to isolate proteins and analyse gene expression are further driving demand for such tools in the rapidly evolving field of molecular biology. 

Scope of the Report: 

Report Metric

Details

Base Year Considered

2024

Forecast Period

2025–2031

CAGR

5.5%

Market Size in 2031

$1.7 Billion


Segments Covered

By Product Type, By Technology, By Sample Type, By Application, By End Use Industry and By Geography.

 





Geographies Covered

North America (U.S., Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Netherlands, Denmark, Belgium and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand, Singapore, Malaysia and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America), Rest of the World (Middle East and Africa).





Key Market Players

1.      Thermo Fisher Scientific Inc.

2.      Bio-Rad Laboratories, Inc.

3.      Danaher Corporation

4.      Merck & Co., Inc.

5.      Cell Signaling Technology, Inc.

6.      Novus Biologicals, LLC

7.      Takara Bio Inc.

8.      Roche Diagnostics GmbH

9.      Promega Corporation

10.  Biologics International Corp.



Recent Developments:

• In August 2024, Merck, acquired Mirus Bio for $600 million. This action furthers Merck's plan to provide a complete and integrated solution for the production of viral vectors.
• In December 2023, Danaher Corporation completed the acquisition of Abcam plc, therefore confirming Abcam as an indirect wholly-owned subsidiary of Danaher.

Immunoprecipitation Market: Competitive Landscape

Key companies profiled in the Immunoprecipitation Market are Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Merck & Co., Inc., Cell Signaling Technology, Inc., Novus Biologicals, LLC, Takara Bio Inc., Roche Diagnostics GmbH, Promega Corporation, Biologics International Corp. and others.

Related Reports:

Bioinformatics Market - Bioinformatics Market Size is forecast to reach $ 21423.6 Million by 2031, at a CAGR of 11.10% during forecast period 2025-2031. Key drivers include advancements in genomics, healthcare, and pharmaceuticals, along with rising investments in R&D and the growing demand for personalized medicine.

Epigenetics Market - Epigenetics Market Size is forecast to reach $ 5,115.20 Million by 2031, at a CAGR of 17.50% during forecast period 2025-2031. The market is driven by increased research into genetic factors, advancements in sequencing technologies, and growing awareness of personalized medicine.

Antibodies Market- Antibodies market size is forecast to reach $247.8 billion by 2026, growing at a CAGR of 12.3% during the forecast period 2021-2026. Drivers include the demand for targeted therapies, rising chronic disease incidences, and advancements in monoclonal antibody technologies.

About IndustryARC™:

IndustryARC primarily focuses on Market Research and Consulting Services specific to Cutting Edge Technologies and Newer Application segments of the market. The company’s Custom Research Services are designed to provide insights into the constant flux in the global demand-supply gap of markets.  
IndustryARC’s goal is to provide the right information required by the stakeholder at the right point in time, in a format that assists an intelligent and informed decision-making process.

Contact Us:

Mr. Venkat Reddy
IndustryARC
USA: (+1) 518-282-4727